RBC says it has partnered with Cohere Inc. to develop generative artificial intelligence products for the financial industry.

What will shape AI governance? Industry leaders share key insights, highlighting diverse yet interconnected factors driving progress in ethics, regulation, and tech.

The FDA wants the developers of medical devices that rely on AI to disclose more detail about how their devices were ...

(AI). AI technologies such as machine learning, computer vision, natural language processing and reinforcement learning ...

2024 was eventful in the life sciences space – and key trends are expected to continue in the new year. Below, we outline key areas to watch in 2025. In recent years, several trends have heightened ...

The US FDA has introduced voluntary guidelines on the level of lead content in processed baby foods sold in the country.

The Food and Drug Administration issued draft guidance Jan. 6 on marketing submissions and lifecycle management for ...

Artificial intelligence (AI) is transforming the health care landscape, from diagnostics to drug development and clinical trials. As AI ...

Zepp Clarity launched its “Try Before You Buy” program at CES 2025 to enhance hearing aid adoption among older adults facing hearing loss. The program allows hands-on experience with advanced models ...

Critics, however, say the move is too little, too late. Other FDA and pharma news is on AI-enabled medical devices, smaller PBMs, and more.

The FDA’s guidance on AI in drug development points to potentially life-threatening consequences of the technology, highlighting the importance of providing the regulator with detailed information ...

The FDA has responded to the increasing use of artificial intelligence (AI) in the discovery and development of drugs and ...